• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

370
62
45
43
20

COUNTRY

42
10
5
5
4

PRICE

136
413
513
1,035

PUBLISHED

24
68
291
1,035

PRODUCT TYPE

1,002
17
11
4
1

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE

2013 U.S. Management and technical consulting services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Management and technical consulting services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry...

May 2013
FROM

2013 U.S. Management of companies and enterprises commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Management of companies and enterprises commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics,...

May 2013
FROM

2013 U.S. Basic chemicals commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Basic chemicals commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics, forecasts and...

May 2013
FROM

2013 U.S. Truck transportation commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Truck transportation commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics, forecasts...

May 2013
FROM

2013 U.S. Advertising and related services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U S Advertising and related services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics,...

May 2013
FROM

2013 U.S. Retail trade commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Retail trade commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics, forecasts and demographics....

May 2013
FROM

2013 U.S. Electronic, commercial, and household goods repair commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Electronic, commercial, and household goods repair commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate...

May 2013
FROM

2013 U.S. Medical equipment and supplies commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Medical equipment and supplies commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics,...

May 2013
FROM

2013 U.S. Ambulatory health care services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Ambulatory health care services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics,...

May 2013
FROM

Multiple Sclerosis Thought Leader Panel #18 2013-05

The Multiple Sclerosis Thought Leader Panel #18 2013-05 summarizes a series of interviews conducted with Neurology Thought leaders after the AAN 2013 The objectives of these discussions was to highlight...

May 2013

2013 U.S. Insurance carriers and related services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report

The 2013 U.S. Insurance carriers and related services commodities or services used by the Psychiatric & Substance Abuse Centers Industry-Input & Output Report contains timely and accurate industry statistics,...

May 2013
FROM

Neuropsychology and Philosophy of Mind in Process

Aims and Scope: This volume celebrates the life achievements of Jason W Brown, who, along with Jean Piaget, Heinz Werner, Alexander Luria and the Würzburg school, has significantly contributed to the...

May 2013
FROM

Inflammatory Pain Global Clinical Trials Review, H1, 2013

Inflammatory Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Inflammatory Pain Global Clinical Trials Review, H1, 2013" provides data on the Inflammatory Pain clinical...

April 2013
FROM

Cancer Pain Global Clinical Trials Review, H1, 2013

Cancer Pain Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Cancer Pain Global Clinical Trials Review, H1, 2013" provides data on the Cancer Pain clinical trial scenario....

April 2013
FROM

Tension -Type Headache Global Clinical Trials Review, H1, 2013

Tension -Type Headache Global Clinical Trials Review, H1, 2013 Summary Our clinical trial report, “Tension -Type Headache Global Clinical Trials Review, H1, 2013" provides data on the Tension -Type...

April 2013
FROM
Sedation - Pipeline Review, H1 2013 Sedation - Pipeline Review, H1 2013 - Product Thumbnail Image

Sedation - Pipeline Review, H1 2013

Sedation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Sedation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information...

April 2013
FROM
Muscle Spasticity - Pipeline Review, H1 2013 Muscle Spasticity - Pipeline Review, H1 2013 - Product Thumbnail Image

Muscle Spasticity - Pipeline Review, H1 2013

Muscle Spasticity – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Spasticity - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report...

April 2013
FROM
Neuropathy - Pipeline Review, H1 2013 Neuropathy - Pipeline Review, H1 2013 - Product Thumbnail Image

Neuropathy - Pipeline Review, H1 2013

Neuropathy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuropathy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Motor Neurone Diseases - Pipeline Review, H1 2013 Motor Neurone Diseases - Pipeline Review, H1 2013 - Product Thumbnail Image

Motor Neurone Diseases - Pipeline Review, H1 2013

Motor Neurone Diseases – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Motor Neurone Diseases - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Disruptive Behavior Disorder - Pipeline Review, H1 2013 Disruptive Behavior Disorder - Pipeline Review, H1 2013 - Product Thumbnail Image

Disruptive Behavior Disorder - Pipeline Review, H1 2013

Disruptive Behavior Disorder – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Disruptive Behavior Disorder - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos